Plain-English translation of NCT07431281 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether , a new targeted cancer medication, works better when combined with other drugs to treat advanced stomach and esophageal cancers. The trial compares this new medication with current standard treatments. Participants will be placed into different treatment groups based on specific characteristics of their cancer.
Current treatments for advanced stomach and esophageal cancer don't work well enough for all patients, and doctors need to find more effective options. This trial is testing whether the new medication can improve survival and quality of life for patients whose cancers have specific genetic markers.
You likely qualify if…
You likely don't qualify if…
Participants will receive one of five different treatment combinations given through infusions or tablets, depending on which group they are randomly assigned to. You will visit the clinic regularly for treatment and monitoring visits to check how well the medication is working and to watch for side effects. The study will continue until your cancer progresses, side effects become too severe, or you decide to stop, and researchers will follow your health for up to several years.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
United States